Los Angeles Fosamax Bone Fracture Attorneys
Since 2001, approximately 2,400 people using Fosamax have developed Osteonecrosis of the Jaw (ONJ). In 2004, health care professionals urged the FDA to issue a warning about Fosamax and its link to ONJ. In 2010, the FDA issued a warning against Fosamax for frequent femur fractures resulting in a labeling change. Contact the pharmaceutical litigation attorneys at Arias, Ozzello & Gignac, LLP if you believe you have suffered injuries as a result of taking Fosamax.
What is Fosamax
Fosamax is a prescription drug used to treat and prevent osteoporosis and other bone diseases in both men and women. It is a bisphosphonate that prevents bone breakdown and increases bone density or thickness for men and for women who have already undergone menopause.
Adverse Side Effects
Fosamax has been linked to osteonecrosis of the jaw (ONJ) and rare bone fractures of the femur. Contact a drug litigation attorney if you have taken Fosamax and have experienced any of the following complications:
- Localized jaw pain
- Numbness or altered sensation in the jaw
- Loosening of teeth
- Soft tissue infections
- Bone exposure in the oral cavity
- Femoral fracture
If you have experienced any of these complications, you may be entitled to compensation for your medical bills, pain, suffering, or other related damages. Our Los Angeles fosamax bone fracture attorneys law office of Arias, Ozzello & Gignac, LLP is currently investigating complaints against Fosamax. To discuss your legal options, contact an experienced pharmaceutical attorney today for a free consultation.